Identifying predictive biomarkers of CIMAvaxEGF success in non–small cell lung cancer patients

BACKGROUND: Immunosenescence biomarkers and peripheral blood parameters are evaluated separately as possible predictive markers of immunotherapy. Here, we illustrate the use of a causal inference model to identify predictive biomarkers of CIMAvaxEGF success in the treatment of Non–Small Cell Lung Ca...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Cancer
Autori principali: Lorenzo-Luaces, Patricia, Sanchez, Lizet, Saavedra, Danay, Crombet, Tania, Van der Elst, Wim, Alonso, Ariel, Molenberghs, Geert, Lage, Agustin
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2020
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7433036/
https://ncbi.nlm.nih.gov/pubmed/32807114
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07284-4
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi